We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.43%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$26.6B
AUM Growth
+$2.81B
(+12%)
Cap. Flow
+$487M
Cap. Flow
% of AUM
1.83%
Top 10 Holdings %
Top 10 Hldgs %
39.26%
Holding
604
New
63
Increased
202
Reduced
200
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$213M |
| 2 |
Apple
AAPL
|
+$167M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$150M |
| 4 |
Walt Disney
DIS
|
+$109M |
| 5 |
lululemon athletica
LULU
|
+$108M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$245M |
| 2 |
Amazon
AMZN
|
+$206M |
| 3 |
Meta Platforms (Facebook)
META
|
+$155M |
| 4 |
Stanley Black & Decker
SWK
|
+$143M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.69% |
| 2 | Healthcare | 22.4% |
| 3 | Consumer Discretionary | 15.48% |
| 4 | Communication Services | 9.79% |
| 5 | Financials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
251
BeOne Medicines Ltd
ONC
$33.8B
| $3.58M | 0.01% |
20,799
+2,811
| +16% | +$473K |
|
|
DOCU
252
DocuSign
DOCU
$10.1B
| $3.52M | 0.01% |
+66,867
| New | +$3.79M |
|
253
Humana
HUM
$45.8B
| $3.48M | 0.01% |
10,271
+7,990
| +350% | +$2.6M |
|
254
Blackrock
BLK
$165B
| $3.32M | 0.01% |
7,040
-22,863
| -76% | -$11.1M |
|
255
Penumbra
PEN
$12.6B
| $3.31M | 0.01% |
22,143
+8,295
| +60% | +$1.16M |
|
256
AstraZeneca
AZN
$263B
| $3.3M | 0.01% |
41,704
+13,000
| +45% | +$983K |
|
257
Procter & Gamble
PG
$346B
| $3.3M | 0.01% |
39,651
+4
| +0% | +$327 |
|
258
Hexcel
HXL
$8.28B
| $3.19M | 0.01% |
47,633
-1,525
| -3% | -$103K |
|
259
Novanta
NOVT
$5.01B
| $3.19M | 0.01% |
46,651
+1,898
| +4% | +$133K |
|
260
Pacira BioSciences
PCRX
$1.04B
| $2.96M | 0.01% |
+60,279
| New | +$2.61M |
|
261
GDS Holdings
GDS
$6.29B
| $2.95M | 0.01% |
83,969
-22,505
| -21% | -$810K |
|
262
Old Dominion Freight Line
ODFL
$47.2B
| $2.86M | 0.01% |
53,196
-1,659
| -3% | -$84K |
|
263
Universal Display
OLED
$3.81B
| $2.82M | 0.01% |
23,940
-56,271
| -70% | -$6.19M |
|
|
SAGE
264
DELISTED
Sage Therapeutics
SAGE
| $2.82M | 0.01% |
19,989
-3,471
| -15% | -$536K |
|
265
Madrigal Pharmaceuticals
MDGL
$12.7B
| $2.73M | 0.01% |
12,746
-2,282
| -15% | -$573K |
|
266
STAAR Surgical
STAA
$1.14B
| $2.71M | 0.01% |
56,394
+22,894
| +68% | +$937K |
|
267
ExxonMobil
XOM
$642B
| $2.67M | 0.01% |
31,410
| – | – |
|
|
ALXN
268
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.52M | 0.01% |
18,100
-5,992
| -25% | -$752K |
|
269
General Dynamics
GD
$105B
| $2.4M | 0.01% |
11,703
-28,126
| -71% | -$5.5M |
|
270
Crown Castle
CCI
$32.4B
| $2.33M | 0.01% |
20,882
-64,249
| -75% | -$7.15M |
|
271
Lennox International
LII
$19B
| $2.32M | 0.01% |
10,627
-16,677
| -61% | -$3.63M |
|
272
Stryker
SYK
$129B
| $2.31M | 0.01% |
13,000
-6,607
| -34% | -$1.13M |
|
|
NVTA
273
DELISTED
Invitae Corporation
NVTA
| $2.31M | 0.01% |
+138,000
| New | +$1.57M |
|
274
Webster Financial
WBS
$12.5B
| $2.29M | 0.01% |
38,748
-3,827
| -9% | -$249K |
|
275
e.l.f. Beauty
ELF
$4.95B
| $2.21M | 0.01% |
173,539
-6,595
| -4% | -$90.7K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2018 Portfolio in Review
As of Q3 2018, Fred Alger Management held 604 positions worth $26.6B, up 12% from $23.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fred Alger Management's Q3 2018 filing shows 63 new, 202 increased, 200 reduced and 70 closed positions. Its largest new stake was lululemon athletica: 790,453 shares worth $128M. The largest sale was Broadcom, an estimated $245M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fred Alger Management's largest Q3 2018 buy was lululemon athletica: 790,453 shares worth $128M.
- Fred Alger Management added most to Thermo Fisher Scientific in Q3 2018, an estimated $213M increase.
- Fred Alger Management's biggest Q3 2018 reduction was Broadcom, cutting an estimated $245M.
- Fred Alger Management fully exited Halliburton in Q3 2018, selling an estimated $32.1M.
- Fred Alger Management's ten largest holdings make up 39% of its $26.6B portfolio in Q3 2018.
- Fred Alger Management opened 63 new positions and closed 70 in Q3 2018.
- Fred Alger Management's portfolio value rose 12% quarter-over-quarter to $26.6B.
Based on Fred Alger Management's 13F filing for Q3 2018, filed 14 Nov 2018.